The International Coalition of Medicines Regulatory Authorities (ICMRA) is a global conference of government health bureaucrats.
[1][2] In 2012, at the margins of the 65th World Health Assembly conference in May the Minister of Health of Brazil proposed an agenda to create a new coalition of Heads of Agency "to address current and emerging human medicine regulatory and safety challenges globally, strategically and in an ongoing, transparent, authoritative and institutional manner.
"As a result, a consensus has emerged on the desirability of developing an ICMRA to address common issues.
"[3] Amongst the reasons cited for this body to be established was "Continued industry and political pressures to harmonise and align regulatory practices and activities.
A key objective of the meeting was to discuss and agree on an approach to the requirements to support first-in-human clinical trials.